Steven Y. Hua

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, Geert D’Haens et al. · New England Journal of Medicine · 2021 · 532 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab

Luis Fayad, Fritz Offner, Mitchell R. Smith et al. · Journal of Clinical Oncology · 2013 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

Brian G. Feagan, William J. Sandborn, Silvio Danese et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 137 citations

Medicine, Clinical Sciences, Gastroenterology +4

Activity of an Alcohol-Based Hand Gel Against Human Adeno-, Rhino-, and Rotaviruses Using the Fingerpad Method

Syed A. Sattar, Makonnen Abebe, Angela J. Bueti et al. · Infection Control and Hospital Epidemiology · 2000 · 110 citations

Life Sciences, Infectious Diseases, Microbiology +12

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

Evan S. Dellon, Margaret H. Collins, Marc E. Rothenberg et al. · Clinical Gastroenterology and Hepatology · 2020 · 98 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15